Emergent BioSolutions to Webcast Presentation at Credit Suisse First Annual Antibody Day

ROCKVILLE, Md.--(BUSINESS WIRE)--Apr. 29, 2013-- Emergent BioSolutions Inc. (NYSE: EBS) announced today that the company will be webcasting its presentation at the Credit Suisse First Annual Antibody Day in New York on May 10, 2013 at 9:30 AM Eastern. During the presentation, a member of the company's management team will provide an overview of the company’s lead clinical development candidate, the TRU-016 ADAPTIR™ (Modular Protein Technology) therapeutic, as well as a discussion of the company’s ADAPTIR platform and certain pre-clinical programs based on the ADAPTIR platform. The webcast of this presentation will be available bo...